More Covid-19 vaccine deaths than expected compared with deaths from influenza vaccines

Waiting for an internal review by Medicines and Healthcare Products Regulatory Agency of their handling of this request.

Dear Medicines and Healthcare Products Regulatory Agency,
At the February 2022 MHRA Board Meeting, Dr Alison Cave explained that the MHRA bases its assessment of adverse reactions of medicines and vaccines by comparison with what is known: "is it [an adverse reaction or death] what we would expect, is it more than we would expect".
As Covid-19 and influenza are similar upper respiratory tract infections, then influenza shall serve as a reasonable comparator for assessing whether deaths following Covid-19 vaccinations are what would be expected or more than expected.
During the three influenza seasons 2017-18, 2018-19 and 2019-20 there were 28 Yellow Card reported deaths following 32,112,955 injections in England of both inactivated and live attenuated vaccines. This is a rate of 0.87 influenza deaths/1m injections.
Since the start of the UK roll out of Covid-19 vaccinations to 10th April 2022 there have been 2075 Yellow Card reported deaths from 117,593,065 injections, a rate of 17.7 deaths/1m injections.
As Covid-19 deaths are 20 times higher than "expected" in comparison with influenza, why has the MHRA not cancelled the Emergency Use Authorisation for deployment of Covid-19 vaccines in the UK?
If you consider a death rate of 17.7 deaths/1m injections to be acceptable, please state what a death rate would have to be to be considered unacceptable

Yours faithfully,

Graham Crawley

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Graham Crawley
<[FOI #856743 email]> Sent: Saturday, April 23,
2022 2:44:02 PM To: MHRA Customer Services Subject: Freedom of Information
request - More Covid-19 vaccine deaths than expected compared with deaths
from influenza vaccines Dear Medicines and Healthcare Products Regulatory
Agency, At the February 2022 MHRA Board Meeting, Dr Alison Cave explained
that the MHRA bases its assessment of adverse reactions of medicines and
vaccines by comparison with what is known: "is it [an adverse reaction or
death] what we would expect, is it more than we would expect". As Covid-19
and influenza are similar upper respiratory tract infections, then
influenza shall serve as a reasonable comparator for assessing whether
deaths following Covid-19 vaccinations are what would be expected or more
than expected. During the three influenza seasons 2017-18, 2018-19 and
2019-20 there were 28 Yellow Card reported deaths following 32,112,955
injections in England of both inactivated and live attenuated vaccines.
This is a rate of 0.87 influenza deaths/1m injections. Since the start of
the UK roll out of Covid-19 vaccinations to 10th April 2022 there have
been 2075 Yellow Card reported deaths from 117,593,065 injections, a rate
of 17.7 deaths/1m injections. As Covid-19 deaths are 20 times higher than
"expected" in comparison with influenza, why has the MHRA not cancelled
the Emergency Use Authorisation for deployment of Covid-19 vaccines in the
UK? If you consider a death rate of 17.7 deaths/1m injections to be
acceptable, please state what a death rate would have to be to be
considered unacceptable Yours faithfully, Graham Crawley
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #856743 email] Is [MHRA request email] the wrong
address for Freedom of Information requests to Medicines and Healthcare
Products Regulatory Agency? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Reference: CSC 97680

 

Dear Mr Crawley,

 

Thank you for your email.

 

We have reviewed your enquiry and this has been passed on to our Vigilance
Risk Management of Medicines colleagues for further input.

 

Should you have any other questions or requests please feel free to call
us on 0203 080 6000 or email at [1][MHRA request email]

 

Our opening hours are Mon – Fri 9am to 5pm (excluding UK Public Holidays)

Kind regards

 

Peter

MHRA Customer Experience Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 0203 080 6000

[2]gov.uk/mhra

[3]Stay connected

 

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: [4]MHRA,
[5]CPRD and [6]NIBSC

 

 

show quoted sections

Dear MHRA Customer Services,
By law you should have replied to this request by 23rd May 2022. You have not. Please reply now

Yours sincerely,

Graham Crawley

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Graham Crawley
<[FOI #856743 email]> Sent: Tuesday, May 24, 2022
7:53:37 AM To: MHRA Customer Services Subject: Re: CSC 97680 - RE: Freedom
of Information request - More Covid-19 vaccine deaths than expected
compared with deaths from influenza vaccines Dear MHRA Customer Services,
By law you should have replied to this request by 23rd May 2022. You have
not. Please reply now Yours sincerely, Graham Crawley -----Original
Message----- Our Reference: CSC 97680 Dear Mr Crawley, Thank you for your
email. We have reviewed your enquiry and this has been passed on to our
Vigilance Risk Management of Medicines colleagues for further input.
Should you have any other questions or requests please feel free to call
us on 0203 080 6000 or email at [1][MHRA request email] Our opening hours
are Mon – Fri 9am to 5pm (excluding UK Public Holidays) Kind regards Peter
MHRA Customer Experience Centre Medicines and Healthcare products
Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000 [2]gov.uk/mhra [3]Stay connected For information
on how the Agency uses your personal data and your data protection rights,
please see our three centres’ Privacy Notices: [4]MHRA, [5]CPRD and
[6]NIBSC
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #856743 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Dear MHRA Customer Services,

Yours sincerely,

Graham Crawley

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Graham Crawley
<[FOI #856743 email]> Sent: Wednesday, July 6, 2022
10:10:28 AM To: MHRA Customer Services Subject: Internal review of Freedom
of Information request - More Covid-19 vaccine deaths than expected
compared with deaths from influenza vaccines Dear MHRA Customer Services,
Yours sincerely, Graham Crawley -----Original Message----- Thank you for
your email. This auto-response is to inform you that your email has been
received and will be reviewed by our Customer Service Team. We will
respond to you as soon as possible. Please note that we may not respond if
your query: • contains offensive language • has already been answered in a
previous reply to you • is illegible • is selling or promoting a product •
is for information only Medicines and Healthcare products Regulatory
Agency 10 South Colonnade, Canary Wharf, London E14 4PU gov.uk/mhra Stay
connected For information on how the Agency uses your personal data and
your data protection rights, please see our three centres’ Privacy
Notices: MHRA, CPRD and NIBSC. The UK has left the EU, and the transition
period ends on 31 December 2020. Ourguidance and information can be
accessed here. ________________________________________ From: Graham
Crawley <[FOI #856743 email]> Sent: Tuesday, May 24, 2022 7:53:37 AM To:
MHRA Customer Services Subject: Re: CSC 97680 - RE: Freedom of Information
request - More Covid-19 vaccine deaths than expected compared with deaths
from influenza vaccines Dear MHRA Customer Services, By law you should
have replied to this request by 23rd May 2022. You have not. Please reply
now Yours sincerely, Graham Crawley -----Original Message----- Our
Reference: CSC 97680 Dear Mr Crawley, Thank you for your email. We have
reviewed your enquiry and this has been passed on to our Vigilance Risk
Management of Medicines colleagues for further input. Should you have any
other questions or requests please feel free to call us on 0203 080 6000
or email at [1][MHRA request email] Our opening hours are Mon – Fri 9am to
5pm (excluding UK Public Holidays) Kind regards Peter MHRA Customer
Experience Centre Medicines and Healthcare products Regulatory Agency 10
South Colonnade, Canary Wharf, London E14 4PU Telephone 0203 080 6000
[2]gov.uk/mhra [3]Stay connected For information on how the Agency uses
your personal data and your data protection rights, please see our three
centres’ Privacy Notices: [4]MHRA, [5]CPRD and [6]NIBSC
------------------------------------------------------------------- Please
use this email address for all replies to this request: [FOI #856743
email] Disclaimer: This message and any reply that you make will be
published on the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #856743 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

CEC 97680

Dear Mr Crawley,

Thank you for your email.

To confirm your enquiry is not being treated under FOI as the request is not seeking recorded information. Your enquiry has been logged under CEC 97680 and is currently in hand with our safety and surveillance team and we hope to respond to you as soon as we can.

Kind Regards

Peter
MHRA Customer Experience Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000
gov.uk/mhra
Stay connected

For information on how the Agency uses your personal data and your data protection rights, please see our three centres' Privacy Notices: MHRA, CPRD and NIBSC

show quoted sections